Home / Cardiovascular system / Ezetimibe
ATC C10AX09 · Lipid Modifying Agents
Ezetimibe shortage
As of 31 Oct 2026, Ezetimibe has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 7 products.
Countries3/5
Products7packs or presentations
Short since1 Jul 202516 months ago
Earliest return12 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EZETIMIBE ACCORD | ACCORD HEALTHCARE, S.L.U. | 1 Jul 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | EZETIMIBE MYLAN | MYLAN S.P.A. | 1 Oct 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | EZETIMIBE ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Apr 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| ES | EZETIMIBA VIATRIS 10 MG COMPRIMIDOS EFG, 28 comprimidos (Blister PVC/PVDC-ALUMINIO) | Viatris Limited | 23 Mar 2026 | 12 Nov 2026 | Not stated |
| BE | Ezetimibe Viatris 10 mg tabl. 100 | Viatris GX | 13 Feb 2026 | 22 Mar 2027 | Manufacturing problem Delay in production |
| BE | Ezetimibe Sandoz 10 mg tabl. 28 | Sandoz | 19 Aug 2026 | 30 Dec 2026 | Manufacturing problem Delay in production |
| BE | Ezetimibe Sandoz 10 mg tabl. 98 | Sandoz | 16 Sep 2026 | 27 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.